|Bid||72.99 x 100|
|Ask||79.60 x 300|
|Day's Range||74.12 - 75.34|
|52 Week Range||43.66 - 78.53|
|PE Ratio (TTM)||69.42|
|Forward Dividend & Yield||0.64 (0.86%)|
|1y Target Est||N/A|
Abaxis' (ABAX) strong performance in Veterinary consumables drives growth. Weak gross and operating margin scenario is a concern.
In fiscal 3Q18, the total revenues generated by Abaxis (ABAX) were $59.6 million compared to $52.7 million in fiscal 3Q17. The gross profit generated by Abaxis was $32.1 million in fiscal 3Q18 compared to $29.4 million in fiscal 3Q17. The research and development expenses incurred by Abaxis in fiscal 3Q18 were $5.1 million compared to $4.7 million in fiscal 3Q17.
Incorporated in California, Abaxis (ABAX) develops, manufactures, and commercializes portable blood analysis systems that are used in a wide range of medical specialties in human or veterinary patient care. The company has worldwide operations and operates in two business segments: the medical market and the veterinary market. Of the ten analysts covering Abaxis in February 2018, two analysts gave the stock “strong buy” ratings, six gave it “hold” ratings, and two gave it “sell” ratings.
Abaxis (ABAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Union City, California-based company said it had net income of 18 cents per share. Earnings, adjusted for pretax expenses, came to 31 cents per share. The results beat Wall Street expectations. The ...
Abaxis Inc (NASDAQ:ABAX) generated a below-average return on equity of 10.31% in the past 12 months, while its industry returned 12.14%. Though ABAX’s recent performance is underwhelming, it is usefulRead More...
On Thursday, Jan. 25, Abaxis (NASDAQ: ABAX ) will release its latest round of earnings. Benzinga's outlook for Abaxis is included in the following report. Earnings and Revenue Abaxis earnings will be near ...
Abaxis' (ABAX) growing portfolio of rapid test menu and a strong performance in Veterinary consumables drive growth. Intense competition in both the Medical and Veterinary markets is a concern.
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ABAXIS, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis ABAXIS, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ABAXIS, Inc. – Becton, Dickinson and Company, IDEXX Laboratories, Inc., Integra LifeSciences Holdings Corporation, West Pharmaceutical Services, Inc., ICU Medical, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Heska Corporation ... Read more (Read more...)
ABAXIS (ABAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.